Literature DB >> 25459185

Hematopoietic stem cell transplantation for primary immunodeficiencies.

Elizabeth Kang1, Andrew Gennery2.   

Abstract

Allogeneic hematopoietic stem cell transplantation has been shown to be curative for well-described as well as newly discovered immunodeficiencies. However, it is difficulty to define a universal transplant regimen given the rarity of these disorders and the varied pathophysiology these disorders encompass. This article discusses those primary immunodeficiencies most commonly treated by hematopoietic stem cell transplant and describes the transplant issues specific to these disorders. Published by Elsevier Inc.

Entities:  

Keywords:  Immune reconstitution; Immunodeficiency; Immunosuppression; Infection; Inflammation

Mesh：

Year:  2014        PMID： 25459185      PMCID： PMC4255564          DOI： 10.1016/j.hoc.2014.08.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  90 in total

1.  Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome.

Authors:  Ayse Metin; Betul Tavil; Fatih Azık; Dilek Azkur; Ikbal Ok-Bozkaya; Can Kocabas; Bahattin Tunc; Duygu Uckan
Journal:  Pediatr Transplant       Date:  2012-01-17

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

3.  Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Authors:  Marina Cavazzana-Calvo; Frédérique Carlier; Françoise Le Deist; Estelle Morillon; Pierre Taupin; David Gautier; Isabelle Radford-Weiss; Sophie Caillat-Zucman; Bénédicte Neven; Stephane Blanche; Rémi Cheynier; Alain Fischer; Salima Hacein-Bey-Abina
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

4.  Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency.

Authors:  Douglas R McDonald; Michel J Massaad; Alicia Johnston; Sevgi Keles; Talal Chatila; Raif S Geha; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

5.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Authors:  Rebecca A Marsh; Gretchen Vaughn; Mi-Ok Kim; Dandan Li; Sonata Jodele; Sarita Joshi; Parinda A Mehta; Stella M Davies; Michael B Jordan; Jack J Bleesing; Alexandra H Filipovich
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

6.  Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.

Authors:  Ansgar S Schulz; Gerhard Glatting; Manfred Hoenig; Catharina Schuetz; Susanne A Gatz; Simon Grewendorf; Monika Sparber-Sauer; Rainer Muche; Norbert Blumstein; Gabriele Kropshofer; Meinolf Suttorp; Donald Bunjes; Klaus-Michael Debatin; Sven N Reske; Wilhelm Friedrich
Journal:  Blood       Date:  2011-02-15       Impact factor: 22.113

7.  Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.

Authors:  A W Flake; M G Roncarolo; J M Puck; G Almeida-Porada; M I Evans; M P Johnson; E M Abella; D D Harrison; E D Zanjani
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

8.  Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients.

Authors:  Jana Pachlopnik Schmid; Despina Moshous; Nathalie Boddaert; Bénédicte Neven; Liliane Dal Cortivo; Marc Tardieu; Marina Cavazzana-Calvo; Stéphane Blanche; Geneviève de Saint Basile; Alain Fischer
Journal:  Blood       Date:  2009-04-29       Impact factor: 22.113

9.  Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.

Authors:  Y Dror; R Gallagher; D W Wara; B W Colombe; A Merino; M Benkerrou; M J Cowan
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561
View more
  3 in total

1.  Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation.

Authors:  Bianca Tesi; Peter Priftakis; Fredrik Lindgren; Samuel C C Chiang; Nikolaos Kartalis; Alexandra Löfstedt; Esther Lörinc; Jan-Inge Henter; Jacek Winiarski; Yenan T Bryceson; Marie Meeths
Journal:  J Clin Immunol       Date:  2016-05-04       Impact factor: 8.317

2.  The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index.

Authors:  Julia Nordin; Leire Solís; Johan Prévot; Nizar Mahlaoui; Helen Chapel; Silvia Sánchez-Ramón; Adli Ali; John W Seymour; Martine Pergent
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

3.  Gonadal failure among female patients after hematopoietic stem cell transplantation for non-malignant diseases.

Authors:  Akito Sutani; Yuichi Miyakawa; Atsumi Tsuji-Hosokawa; Risa Nomura; Ryuichi Nakagawa; Keisuke Nakajima; Mitsue Maru; Yuki Aoki; Kei Takasawa; Masatoshi Takagi; Kohsuke Imai; Kenichi Kashimada; Tomohiro Morio
Journal:  Clin Pediatr Endocrinol       Date:  2019-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.